Amedeo Smart

Free Medical Literature Service




  Free Subscription

Articles published in
Lancet Neurol
    August 2022
  1. BRAININ M, Grisold W, Hankey GJ, Norrving B, et al
    Time to revise primary prevention guidelines for stroke and cardiovascular disease.
    Lancet Neurol. 2022;21:686-687.
    >> Share

    June 2022
  2. BAAK LM, Wagenaar N, van der Aa NE, Groenendaal F, et al
    Feasibility and safety of intranasally administered mesenchymal stromal cells after perinatal arterial ischaemic stroke in the Netherlands (PASSIoN): a first-in-human, open-label intervention study.
    Lancet Neurol. 2022;21:528-536.
    >> Share

  3. GONZALEZ F, Ferriero DM
    Stem cells for perinatal stroke.
    Lancet Neurol. 2022;21:497-499.
    >> Share

    No area of stroke research should be left behind.
    Lancet Neurol. 2022;21:495.
    >> Share

    May 2022
    20 years of improvement in stroke care: the rewards from finally funding more research.
    Lancet Neurol. 2022;21:402-404.
    >> Share

    April 2022
  6. BIVARD A, Zhao H, Churilov L, Campbell BCV, et al
    Comparison of tenecteplase with alteplase for the early treatment of ischaemic stroke in the Melbourne Mobile Stroke Unit (TASTE-A): a phase 2, randomised, open-label trial.
    Lancet Neurol. 2022 Apr 29. pii: S1474-4422(22)00171.
    >> Share

  7. KVISTAD CE, Naess H, Helleberg BH, Idicula T, et al
    Tenecteplase versus alteplase for the management of acute ischaemic stroke in Norway (NOR-TEST 2, part A): a phase 3, randomised, open-label, blinded endpoint, non-inferiority trial.
    Lancet Neurol. 2022 Apr 29. pii: S1474-4422(22)00124.
    >> Share

    Tenecteplase for acute stroke: the thrombolysis puzzle.
    Lancet Neurol. 2022 Apr 29. pii: S1474-4422(22)00172.
    >> Share

  9. HILL G, Regan S, Francis R
    Research priorities to improve stroke outcomes.
    Lancet Neurol. 2022;21:312-313.
    >> Share

    March 2022
  10. BONATI LH, Jansen O, de Borst GJ, Brown MM, et al
    Management of atherosclerotic extracranial carotid artery stenosis.
    Lancet Neurol. 2022;21:273-283.
    >> Share

    February 2022
  11. ZHAO J, Yuan F, Song C, Yin R, et al
    Safety and efficacy of three enteral feeding strategies in patients with severe stroke in China (OPENS): a multicentre, prospective, randomised, open-label, blinded-endpoint trial.
    Lancet Neurol. 2022 Feb 24. pii: S1474-4422(22)00010.
    >> Share

    Nutrition in acute stroke management: food for thought.
    Lancet Neurol. 2022 Feb 24. pii: S1474-4422(22)00078.
    >> Share

  13. GUTIERREZ J, Turan TN, Hoh BL, Chimowitz MI, et al
    Intracranial atherosclerotic stenosis: risk factors, diagnosis, and treatment.
    Lancet Neurol. 2022 Feb 7. pii: S1474-4422(21)00376.
    >> Share

    Jeyaraj Pandian: passionate about improving stroke care in India.
    Lancet Neurol. 2022;21:120.
    >> Share

    January 2022
  15. BAILLIEUL S, Dekkers M, Brill AK, Schmidt MH, et al
    Sleep apnoea and ischaemic stroke: current knowledge and future directions.
    Lancet Neurol. 2022;21:78-88.
    >> Share

  16. PUY L, Cordonnier C
    Stroke research in 2021: insights into the reorganisation of stroke care.
    Lancet Neurol. 2022;21:2-3.
    >> Share

    December 2021
    Primary stroke prevention: useful thresholds?
    Lancet Neurol. 2021 Dec 16. pii: S1474-4422(21)00458.
    >> Share

    November 2021
  18. SCHREUDER FHBM, van Nieuwenhuizen KM, Hofmeijer J, Vermeer SE, et al
    Apixaban versus no anticoagulation after anticoagulation-associated intracerebral haemorrhage in patients with atrial fibrillation in the Netherlands (APACHE-AF): a randomised, open-label, phase 2 trial.
    Lancet Neurol. 2021;20:907-916.
    >> Share

    September 2021
  19. PANDIAN JD, Sebastian IA
    Integrated approach to stroke burden: are we doing enough?
    Lancet Neurol. 2021 Sep 3. pii: S1474-4422(21)00287.
    >> Share

  20. Global, regional, and national burden of stroke and its risk factors, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.
    Lancet Neurol. 2021 Sep 3. pii: S1474-4422(21)00252.
    >> Share

  21. CASO V, Mosconi MG
    Lessons to be learned in intracerebral haemorrhage research.
    Lancet Neurol. 2021 Sep 2. pii: S1474-4422(21)00296.
    >> Share

  22. HOWARD DPJ, Rothwell PM
    Asymptomatic carotid stenosis and stroke risk - Authors' reply.
    Lancet Neurol. 2021;20:699.
    >> Share

  23. ABBOTT A
    Asymptomatic carotid stenosis and stroke risk.
    Lancet Neurol. 2021;20:698-699.
    >> Share

  24. ROTHWELL PM, Buchan AM
    A new thrombolytic drug for acute ischaemic stroke.
    Lancet Neurol. 2021;20:687-689.
    >> Share

  25. GUSEV EI, Martynov MY, Nikonov AA, Shamalov NA, et al
    Non-immunogenic recombinant staphylokinase versus alteplase for patients with acute ischaemic stroke 4.5 h after symptom onset in Russia (FRIDA): a randomised, open label, multicentre, parallel-group, non-inferiority trial.
    Lancet Neurol. 2021;20:721-728.
    >> Share

    July 2021
  26. BANDINI F, Vestito L, Filippi L
    Prehospital scales in acute ischaemic stroke management.
    Lancet Neurol. 2021;20:504.
    >> Share

  27. DUVEKOT MHC, Venema E, Kerkhoff H, Dippel DWJ, et al
    Prehospital scales in acute ischaemic stroke management - Authors' reply.
    Lancet Neurol. 2021;20:504-505.
    >> Share

    June 2021
  28. LI L, Poon MTC, Samarasekera NE, Perry LA, et al
    Risks of recurrent stroke and all serious vascular events after spontaneous intracerebral haemorrhage: pooled analyses of two population-based studies.
    Lancet Neurol. 2021;20:437-447.
    >> Share

  29. HAEUSLER KG, Kirchhof P, Kunze C, Tutuncu S, et al
    Systematic monitoring for detection of atrial fibrillation in patients with acute ischaemic stroke (MonDAFIS): a randomised, open-label, multicentre study.
    Lancet Neurol. 2021;20:426-436.
    >> Share

  30. CHENG X, Dong Q
    Towards individualised secondary prevention after intracerebral haemorrhage.
    Lancet Neurol. 2021;20:411-413.
    >> Share

  31. WASSERLAUF J, Volgman AS
    Monitoring for atrial fibrillation after stroke.
    Lancet Neurol. 2021;20:410-411.
    >> Share

    May 2021
    Michael Moskowitz: solving the puzzle of migraine.
    Lancet Neurol. 2021 May 17. pii: S1474-4422(21)00141.
    >> Share

  33. JORDAN LC, DeBaun MR, Donahue MJ
    Advances in neuroimaging to improve care in sickle cell disease.
    Lancet Neurol. 2021;20:398-408.
    >> Share

  34. HACHINSKI V, Avan A, Gilliland J, Oveisgharan S, et al
    A new definition of brain health.
    Lancet Neurol. 2021;20:335-336.
    >> Share

    April 2021
  35. WEAVER NA, Kuijf HJ, Aben HP, Abrigo J, et al
    Strategic infarct locations for post-stroke cognitive impairment: a pooled analysis of individual patient data from 12 acute ischaemic stroke cohorts.
    Lancet Neurol. 2021 Apr 23. pii: S1474-4422(21)00060.
    >> Share

  36. PANTONI L, Salvadori E
    Location of infarcts and post-stroke cognitive impairment.
    Lancet Neurol. 2021 Apr 23. pii: S1474-4422(21)00107.
    >> Share

  37. BEST JG, Ambler G, Wilson D, Lee KJ, et al
    Development of imaging-based risk scores for prediction of intracranial haemorrhage and ischaemic stroke in patients taking antithrombotic therapy after ischaemic stroke or transient ischaemic attack: a pooled analysis of individual patient data from
    Lancet Neurol. 2021;20:294-303.
    >> Share

    Cerebral microbleeds and prediction of intracranial haemorrhage.
    Lancet Neurol. 2021;20:252-254.
    >> Share

  39. ZIAI WC, Al-Kawaz M
    Blood pressure management after endovascular therapy.
    Lancet Neurol. 2021;20:248-249.
    >> Share

  40. LAUMANN TO, Ortega M, Hoyt CR, Seider NA, et al
    Brain network reorganisation in an adolescent after bilateral perinatal strokes.
    Lancet Neurol. 2021;20:255-256.
    >> Share

    March 2021
  41. SCHMIDT R, Hofer E
    Identifying novel genetic risk loci for lacunar stroke.
    Lancet Neurol. 2021 Mar 25. pii: S1474-4422(21)00099.
    >> Share

  42. TRAYLOR M, Persyn E, Tomppo L, Klasson S, et al
    Genetic basis of lacunar stroke: a pooled analysis of individual patient data and genome-wide association studies.
    Lancet Neurol. 2021 Mar 25. pii: S1474-4422(21)00031.
    >> Share

  43. ENGELTER ST, Traenka C, Gensicke H, Schaedelin SA, et al
    Aspirin versus anticoagulation in cervical artery dissection (TREAT-CAD): an open-label, randomised, non-inferiority trial.
    Lancet Neurol. 2021 Mar 22. pii: S1474-4422(21)00044.
    >> Share

  44. HOWARD DPJ, Gaziano L, Rothwell PM
    Risk of stroke in relation to degree of asymptomatic carotid stenosis: a population-based cohort study, systematic review, and meta-analysis.
    Lancet Neurol. 2021;20:193-202.
    >> Share

  45. VAN DIJCK JTJM, Kompanje EJO, Nederkoorn PJ, Peul WC, et al
    Advanced consent for acute stroke trials - Authors' reply.
    Lancet Neurol. 2021;20:170-171.
    >> Share

  46. SHAMY M, Dewar B, Niznick N, Nicholls S, et al
    Advanced consent for acute stroke trials.
    Lancet Neurol. 2021;20:170.
    >> Share

    Treatment of asymptomatic carotid stenosis.
    Lancet Neurol. 2021;20:163-165.
    >> Share

    February 2021
  48. MAZIGHI M, Richard S, Lapergue B, Sibon I, et al
    Safety and efficacy of intensive blood pressure lowering after successful endovascular therapy in acute ischaemic stroke (BP-TARGET): a multicentre, open-label, randomised controlled trial.
    Lancet Neurol. 2021 Feb 26. pii: S1474-4422(20)30483.
    >> Share

    January 2021
  49. DUVEKOT MHC, Venema E, Rozeman AD, Moudrous W, et al
    Comparison of eight prehospital stroke scales to detect intracranial large-vessel occlusion in suspected stroke (PRESTO): a prospective observational study.
    Lancet Neurol. 2021 Jan 7. pii: S1474-4422(20)30439.
    >> Share

  50. GOYAL M, Marko M
    Optimising prehospital stroke triage in a changing landscape.
    Lancet Neurol. 2021 Jan 7. pii: S1474-4422(20)30488.
    >> Share

  51. TSIVGOULIS G, Katsanos AH
    Important advances in stroke research in 2020.
    Lancet Neurol. 2021;20:2-3.
    >> Share

    December 2020
  52. WU S, Anderson CS
    Healthy eating for secondary stroke prevention.
    Lancet Neurol. 2020 Dec 18. pii: S1474-4422(20)30450.
    >> Share

  53. ENGLISH C, MacDonald-Wicks L, Patterson A, Attia J, et al
    The role of diet in secondary stroke prevention.
    Lancet Neurol. 2020 Dec 18. pii: S1474-4422(20)30433.
    >> Share

  54. SILBERGLEIT R, Dickert NW
    Context and principles must drive alternatives to consent in emergency research.
    Lancet Neurol. 2020;19:968-969.
    >> Share

    November 2020
    A unified European action plan on stroke.
    Lancet Neurol. 2020 Nov 6. pii: S1474-4422(20)30409.
    >> Share

    October 2020
  56. MERETOJA A, Yassi N, Wu TY, Churilov L, et al
    Tranexamic acid in patients with intracerebral haemorrhage (STOP-AUST): a multicentre, randomised, placebo-controlled, phase 2 trial.
    Lancet Neurol. 2020 Oct 28. pii: S1474-4422(20)30369.
    >> Share

  57. KOMPANJE EJO, van Dijck JTJM, Chalos V, van den Berg SA, et al
    Informed consent procedures for emergency interventional research in patients with traumatic brain injury and ischaemic stroke.
    Lancet Neurol. 2020 Oct 21. pii: S1474-4422(20)30276.
    >> Share

    September 2020
  58. FIFI JT, Mocco J
    COVID-19 related stroke in young individuals.
    Lancet Neurol. 2020;19:713-715.
    >> Share

    August 2020

  59. Safety and efficacy of fluoxetine on functional recovery after acute stroke (EFFECTS): a randomised, double-blind, placebo-controlled trial.
    Lancet Neurol. 2020;19:661-669.
    >> Share

  60. Safety and efficacy of fluoxetine on functional outcome after acute stroke (AFFINITY): a randomised, double-blind, placebo-controlled trial.
    Lancet Neurol. 2020;19:651-660.
    >> Share

  61. KWAKKEL G, Meskers C, Ward NS
    Time for the next stage of stroke recovery trials.
    Lancet Neurol. 2020;19:636-637.
    >> Share

    July 2020
  62. FASSBENDER K, Walter S, Grunwald IQ, Merzou F, et al
    Prehospital stroke management in the thrombectomy era.
    Lancet Neurol. 2020;19:601-610.
    >> Share

  63. MOHR JP, Overbey JR, Hartmann A, Kummer RV, et al
    Medical management with interventional therapy versus medical management alone for unruptured brain arteriovenous malformations (ARUBA): final follow-up of a multicentre, non-blinded, randomised controlled trial.
    Lancet Neurol. 2020;19:573-581.
    >> Share

    May 2020
  64. HURFORD R, Wolters FJ, Li L, Lau KK, et al
    Prevalence, predictors, and prognosis of symptomatic intracranial stenosis in patients with transient ischaemic attack or minor stroke: a population-based cohort study.
    Lancet Neurol. 2020;19:413-421.
    >> Share

  65. HERMANN DM, Bassetti CL, Marx U, Audoli-Inthavong ML, et al
    Refining endpoints for stroke recovery trials.
    Lancet Neurol. 2020;19:381-382.
    >> Share

    Intensive medical management of intracranial arterial stenosis.
    Lancet Neurol. 2020;19:371-373.
    >> Share

    The fight against stroke must go on.
    Lancet Neurol. 2020;19:369.
    >> Share

  68. MORGAN J
    Werner Hacke: a new era for stroke patients.
    Lancet Neurol. 2020;19:387.
    >> Share

    March 2020
  69. CHABRIAT H, Bassetti CL, Marx U, Audoli-Inthavong ML, et al
    Safety and efficacy of GABAA alpha5 antagonist S44819 in patients with ischaemic stroke: a multicentre, double-blind, randomised, placebo-controlled trial.
    Lancet Neurol. 2020;19:226-233.
    >> Share

    Issues important to the design of stroke recovery trials.
    Lancet Neurol. 2020;19:197-198.
    >> Share

  71. GOYAL M, Ospel J
    Challenges to stroke care 5 years after endovascular therapy became the standard.
    Lancet Neurol. 2020;19:210-211.
    >> Share

    January 2020
  72. STINEAR CM, Lang CE, Zeiler S, Byblow WD, et al
    Advances and challenges in stroke rehabilitation.
    Lancet Neurol. 2020 Jan 28. pii: S1474-4422(19)30415.
    >> Share

  73. WU S, Cheng Y, Wu B, Liu M, et al
    Stroke research in 2019: towards optimising treatment and prevention.
    Lancet Neurol. 2020;19:2-3.
    >> Share

    December 2019
    BEST evidence on mechanical thrombectomy for patients with vertebrobasilar occlusion.
    Lancet Neurol. 2019 Dec 9. pii: S1474-4422(19)30477.
    >> Share

  75. LIU X, Dai Q, Ye R, Zi W, et al
    Endovascular treatment versus standard medical treatment for vertebrobasilar artery occlusion (BEST): an open-label, randomised controlled trial.
    Lancet Neurol. 2019 Dec 9. pii: S1474-4422(19)30395.
    >> Share

    November 2019
  76. AHMADI M, Laumeier I, Ihl T, Steinicke M, et al
    A support programme for secondary prevention in patients with transient ischaemic attack and minor stroke (INSPiRE-TMS): an open-label, randomised controlled trial.
    Lancet Neurol. 2019 Nov 7. pii: S1474-4422(19)30369.
    >> Share

  77. LI L
    Support programme for secondary prevention of stroke: inspiration to continue?
    Lancet Neurol. 2019 Nov 7. pii: S1474-4422(19)30410.
    >> Share

  78. BAYONA-ORTIZ H, Useche JN, Yanez N, Velasco SC, et al
    Availability of stroke units in Colombia.
    Lancet Neurol. 2019;18:988.
    >> Share

    October 2019
    Global prevention of stroke: focus on the individual?
    Lancet Neurol. 2019;18:903.
    >> Share

    September 2019
  80. FLOEL A
    Computerised speech and language therapy in post-stroke aphasia.
    Lancet Neurol. 2019;18:806-807.
    >> Share

  81. PALMER R, Dimairo M, Cooper C, Enderby P, et al
    Self-managed, computerised speech and language therapy for patients with chronic aphasia post-stroke compared with usual care or attention control (Big CACTUS): a multicentre, single-blinded, randomised controlled trial.
    Lancet Neurol. 2019;18:821-833.
    >> Share

    July 2019
  82. SAPOSNIK G, Hachinski V
    The pathway towards an effective reduction of stroke burden worldwide: teamwork.
    Lancet Neurol. 2019;18:622-623.
    >> Share

    June 2019
  83. HILL MD, Benavente OR
    The uncertain role for phosphodiesterase inhibitors in stroke prevention.
    Lancet Neurol. 2019;18:515-517.
    >> Share

    Dopamine for motor recovery after stroke: where to from here?
    Lancet Neurol. 2019;18:514-515.
    >> Share

  85. FORD GA, Bhakta BB, Cozens A, Hartley S, et al
    Safety and efficacy of co-careldopa as an add-on therapy to occupational and physical therapy in patients after stroke (DARS): a randomised, double-blind, placebo-controlled trial.
    Lancet Neurol. 2019;18:530-538.
    >> Share

    Adding stroke to the political agenda in Europe.
    Lancet Neurol. 2019;18:513.
    >> Share

    May 2019
  87. TSIVGOULIS G, Katsanos AH
    Can cerebral microbleeds predict stroke recurrence?
    Lancet Neurol. 2019 May 22. pii: S1474-4422(19)30194.
    >> Share

    Antiplatelets after intracerebral haemorrhage: treat the patient, not the brain imaging.
    Lancet Neurol. 2019 May 21. pii: S1474-4422(19)30189.
    >> Share

    April 2019
  89. DICHGANS M, Pulit SL, Rosand J
    Stroke genetics: discovery, biology, and clinical applications.
    Lancet Neurol. 2019 Apr 8. pii: S1474-4422(19)30043.
    >> Share

    Stroke epidemiology in China: which are the next steps?
    Lancet Neurol. 2019;18:325-326.
    >> Share

  91. WU S, Wu B, Liu M, Chen Z, et al
    Stroke in China: advances and challenges in epidemiology, prevention, and management.
    Lancet Neurol. 2019;18:394-405.
    >> Share

    March 2019

  92. Global, regional, and national burden of stroke, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.
    Lancet Neurol. 2019 Mar 11. pii: S1474-4422(19)30034.
    >> Share

    The global burden of stroke: persistent and disabling.
    Lancet Neurol. 2019 Mar 11. pii: S1474-4422(19)30030.
    >> Share

  94. MELIS M, Ricci S, Toni D
    Optimal stroke prevention in patients with PFO.
    Lancet Neurol. 2019;18:231.
    >> Share

    Dementia risk after transient ischaemic attack and stroke.
    Lancet Neurol. 2019;18:223-225.
    >> Share

    Prasugrel or clopidogrel for long-term secondary stroke prevention?
    Lancet Neurol. 2019;18:222-223.
    >> Share

  97. PENDLEBURY ST, Rothwell PM
    Incidence and prevalence of dementia associated with transient ischaemic attack and stroke: analysis of the population-based Oxford Vascular Study.
    Lancet Neurol. 2019;18:248-258.
    >> Share

    January 2019
  98. WARDLAW JM, Bath PM
    Stroke research in 2018: extended time windows, refined benefit, and lifestyle prevention targets.
    Lancet Neurol. 2019;18:2-3.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016